AIM-1290
AIM-1290 is a PfFPPS/GGPPS inhibitor with an IC50 of 1.94 μM. AIM-1290 inhibits GGPP production by the bifunctional Plasmodium falciparum farnesyl/geranylgeranyl diphosphate synthase. AIM-1290 inhibits blood-stage Plasmodium falciparum growth. AIM-1290 shows in vitro ADME properties and a mouse pharmacokinetic profile. AIM-1290 can be used for the research of malaria.
For research use only. We do not sell to patients.
- CAS No.: 2642233-93-8
- Formula: C18H21F2N3O2S
- Molecular Weight:381.44
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Parasite Isoforms
More
Biological Activity
Description
In Vitro
AIM-1290 (up to 200 µM) shows no inhibition of HsFPPS or HsGGPPS at concentrations up to 200 µM in project selectivity counter-screens[1].
The human liver microsomal clearance of AIM-1290 is < 1 µL/min/mg, and its mouse liver microsomal clearance is 22 µL/min/mg[1].
The LLC-PK1-MDR1 Papp of AIM-1290 is 92 nm/s, with an efflux ratio of 1.5[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2642233-93-8
-
Molecular Weight 381.44
-
Formula C18H21F2N3O2S
-
SMILES
O=C(CCCN1CCOCCC1)NC2=CN=C(C3=C(F)C=C(F)C=C3)S2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)